Financials
- Market Capitalization 9.44 M
- Employee 24
- Founded 2003
- CEO Philip A. Serlin
- Website www.biolinerx.com
- Headquarter Israel
- FIGI BBG001Y26LK0
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4677 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 0.43 USD | -15.69% | -33.85% | -72.96% | -95.54% | 9.75 M USD | ||
| 4678 | LSTA Lisata Therapeutics, Inc. - Common Stock | 1.08 USD | +2.86% | -11.48% | -29.41% | -54.04% | 9.73 M USD | ||
| 4685 | MTVA MetaVia Inc. - Common Stock | 1.43 USD | -1.38% | -4.03% | -11.18% | +41.58% | 9.42 M USD | ||
| 4687 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.21 USD | -8.70% | -16.00% | -16.00% | -59.23% | 9.32 M USD |